![Medical Advisory #423: CSL Behring Discontinues Production and Distribution of Monoclate-P® | National Hemophilia Foundation Medical Advisory #423: CSL Behring Discontinues Production and Distribution of Monoclate-P® | National Hemophilia Foundation](https://www.hemophilia.org/sites/default/files/styles/crop_1440x570/public/image/medical-advisory-v2.png?h=b93a1d03&itok=79_neFrh)
Medical Advisory #423: CSL Behring Discontinues Production and Distribution of Monoclate-P® | National Hemophilia Foundation
![ANTIHEMOPHILIC FACTOR (FACTOR VIII), HUMAN - INJECTION Alphanate - Uses, Precautions, Side Effects, Interaction, Warnings ANTIHEMOPHILIC FACTOR (FACTOR VIII), HUMAN - INJECTION Alphanate - Uses, Precautions, Side Effects, Interaction, Warnings](https://medic.hrt.org//public/drugs/BAX39460.jpg)
ANTIHEMOPHILIC FACTOR (FACTOR VIII), HUMAN - INJECTION Alphanate - Uses, Precautions, Side Effects, Interaction, Warnings
![Medical Advisory #423: CSL Behring Discontinues Production and Distribution of Monoclate-P® | National Hemophilia Foundation Medical Advisory #423: CSL Behring Discontinues Production and Distribution of Monoclate-P® | National Hemophilia Foundation](https://www.hemophilia.org/sites/default/files/styles/event_teaser/public/image/medical-advisory.png?itok=RsjBmemh)
Medical Advisory #423: CSL Behring Discontinues Production and Distribution of Monoclate-P® | National Hemophilia Foundation
![Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A | Semantic Scholar Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9a65415760166b71f9c7907362267a9ee85af6cd/3-Figure1-1.png)
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A | Semantic Scholar
Utah Medicaid Pharmacy and Therapeutics Committee Drug Class Review Factor VIII Replacement Products Indicated for Hemophilia A
![ANTIHEMOPHILIC FACTOR (FACTOR VIII), HUMAN - INJECTION Alphanate - Uses, Precautions, Side Effects, Interaction, Warnings ANTIHEMOPHILIC FACTOR (FACTOR VIII), HUMAN - INJECTION Alphanate - Uses, Precautions, Side Effects, Interaction, Warnings](https://medic.hrt.org//public/drugs/BAX39440.jpg)